Determining therapeutic susceptibility in multiple myeloma by single-cell mass accumulation

Determining therapeutic susceptibility in multiple myeloma by single-cell mass accumulation

Multiple myeloma (MM) has benefited from significant advancements in treatment that have improved outcomes and reduced morbidity. However, the disease remains incurable and is characterized by high rates of drug resistance and relapse. Consequently, methods to select the most efficacious therapy are...

Full description

Bibliographic Details
Main Authors: Cetin, Arif Engin (Contributor), Stevens, Mark M. (Contributor), Calistri, Nicholas L (Contributor), Olcum, Selim A. (Contributor), Kimmerling, Robert John (Contributor), Manalis, Scott R (Contributor)
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Massachusetts Institute of Technology. Department of Mechanical Engineering (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor)
Format: Article
Language:English
Published: Nature Publishing Group, 2017-11-28T20:49:38Z.
Subjects:
Article
Online Access:Get fulltext

Internet

Get fulltext

Similar Items